VentriPoint Diagnostics (CVE:VPT) Trading Up 6.9%

VentriPoint Diagnostics Ltd. (CVE:VPTGet Free Report) shares were up 6.9% during trading on Friday . The stock traded as high as C$0.16 and last traded at C$0.16. Approximately 181,550 shares traded hands during trading, an increase of 31% from the average daily volume of 138,994 shares. The stock had previously closed at C$0.15.

VentriPoint Diagnostics Stock Performance

The firm has a market capitalization of C$24.31 million, a PE ratio of -5.17 and a beta of 0.27. The firm has a 50-day moving average price of C$0.19 and a 200 day moving average price of C$0.20. The company has a quick ratio of 6.67, a current ratio of 3.09 and a debt-to-equity ratio of 18.47.

About VentriPoint Diagnostics

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.

Featured Stories

Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with's FREE daily email newsletter.